MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition. (Q38832432)
Jump to navigation
Jump to search
scientific article published on 25 September 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition. |
scientific article published on 25 September 2015 |
Statements
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition (English)
Matthew J Fell
Christian Mirescu
Kallol Basu
Boonlert Cheewatrakoolpong
Duane E DeMong
Yinghui Lin
Carrie G Markgraf
Hong Mei
Michael Miller
Frederique M Poulet
Jack D Scott
Michelle D Smith
Zhizhang Yin
Xiaoping Zhou
Eric M Parker
Matthew E Kennedy
25 September 2015